• Title/Summary/Keyword: asthma : inflammation

검색결과 265건 처리시간 0.026초

The Role of Autophagy in Eosinophilic Airway Inflammation

  • Jinju Lee;Hun Sik Kim
    • IMMUNE NETWORK
    • /
    • 제19권1호
    • /
    • pp.5.1-5.12
    • /
    • 2019
  • Autophagy is a homeostatic mechanism that discards not only invading pathogens but also damaged organelles and denatured proteins via lysosomal degradation. Increasing evidence suggests a role for autophagy in inflammatory diseases, including infectious diseases, Crohn's disease, cystic fibrosis, and pulmonary hypertension. These studies suggest that modulating autophagy could be a novel therapeutic option for inflammatory diseases. Eosinophils are a major type of inflammatory cell that aggravates airway inflammatory diseases, particularly corticosteroid-resistant inflammation. The eosinophil count is a useful tool for assessing which patients may benefit from inhaled corticosteroid therapy. Recent studies demonstrate that autophagy plays a role in eosinophilic airway inflammatory diseases by promoting airway remodeling and loss of function. Genetic variant in the autophagy gene ATG5 is associated with asthma pathogenesis, and autophagy regulates apoptotic pathways in epithelial cells in individuals with chronic obstructive pulmonary disease. Moreover, autophagy dysfunction leads to severe inflammation, especially eosinophilic inflammation, in chronic rhinosinusitis. However, the mechanism underlying autophagy-mediated regulation of eosinophilic airway inflammation remains unclear. The aim of this review is to provide a general overview of the role of autophagy in eosinophilic airway inflammation. We also suggest that autophagy may be a new therapeutic target for airway inflammation, including that mediated by eosinophils.

마우스 모델을 이용한 사이프러스 오일의 알러지성 천식 억제 효과 (Anti-asthmatic activities of Cypress oil in a mouse model of allergic asthma)

  • 승윤철;정규진;정광조
    • 디지털융복합연구
    • /
    • 제13권1호
    • /
    • pp.341-351
    • /
    • 2015
  • 본 연구는 천식 생쥐 모델을 이용하여 사이프러스 오일(CS)이 알러지성 천식에 미치는 영향을 평가하기 위하여 수행되었다. Ovalbumin으로 천식을 유발시킨 천식 생쥐 모델을 사용하여 실험군에 0.3% CS를 3 주간, 1주 3회, 1회 30분간 분무기를 이용하여 흡입시켰다. 기도과민성, 백혈구 중 호산구 수, 폐 세포 내 면역세포와 Th2 싸이토카인의 변화를 관찰한 결과 CS를 처리한 실험군에서 기도과민성, 호산구 수 및 폐 세포 내 IL-5,IL-13 수치, 혈청내 IgE 분비량, 폐 세포 내 CCR3, CD3, CD4 세포의 수 등 모든 항목에서 현저한 감소효과를 보였다. 이러한 결과는 CS가 천식 반응의 주요인자인 Th2 싸이토카인과 호산구에 긍정적인 영향력이 있음을 시사한다. 따라서 CS는 천식 치료제로서 가능성이 있을 것으로 사료된다.

Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma

  • Kang, Ji Young;Kim, In Kyoung;Hur, Jung;Kim, Seok Chan;Lee, Sook Young;Kwon, Soon Seog;Kim, Young Kyoon
    • Tuberculosis and Respiratory Diseases
    • /
    • 제82권1호
    • /
    • pp.71-80
    • /
    • 2019
  • Background: Efficacy and safety of tiotropium bromide, a muscarinic receptor antagonist, in treatment of asthma have been reported. However, its effect on airway remodeling in chronic asthma of the elderly has not been clearly verified. The objective of this study was to investigate the effect of tiotropium and expression of muscarinic receptors as its related mechanism in an aged mouse model of chronic asthma with airway remodeling. Methods: BALB/c female mice age 6 weeks, 9 and 15 months were sensitized and challenged with ovalbumin (OVA) for three months. Tiotropium bromide was administered during the challenge period. Airway hyperresponsiveness (AHR) and pulmonary inflammation were measured. Parameters of airway remodeling, and expression levels of $M_2$ and $M_3$ receptors were examined. Results: Total cell with eosinophils, increased in the OVA groups by age, was decreased significantly after treatment with tiotropium bromide, particularly in the age group of 15 months. AHR and levels of interleukin (IL)-4, IL-5, and IL-13 were decreased, after tiotropium administration. In old aged group of 9- and 15-months-treated groups, hydroxyproline contents and levels of ${\alpha}$-smooth muscle actin were attenuated. Tiotropium enhanced the expression of $M_2$ but decreased expression of $M_3$ in all aged groups of OVA. Conclusion: Tiotropium bromide had anti-inflammatory and anti-remodeling effects in an aged mouse model of chronic asthma. Its effects seemed to be partly mediated by modulating expression $M_3$ and $M_2$ muscarinic receptors. Tiotropium may be a beneficial treatment option for the elderly with airway remodeling of chronic asthma.

Suppressive Effect of CYM50358 S1P4 Antagonist on Mast Cell Degranulation and Allergic Asthma in Mice

  • Jeon, Wi-Jin;Chung, Ki Wung;Lee, Joon-Hee;Im, Dong-Soon
    • Biomolecules & Therapeutics
    • /
    • 제29권5호
    • /
    • pp.492-497
    • /
    • 2021
  • Levels of sphingosine 1-phosphate (S1P), an intercellular signaling molecule, reportedly increase in the bronchoalveolar lavage fluids of patients with asthma. Although the type 4 S1P receptor, S1P4 has been detected in mast cells, its functions have been poorly investigated in an allergic asthma model in vivo. S1P4 functions were evaluated following treatment of CYM50358, a selective antagonist of S1P4, in an ovalbumin-induced allergic asthma model, and antigen-induced degranulation of mast cells. CYM50358 inhibited antigen-induced degranulation in RBL-2H3 mast cells. Eosinophil accumulation and an increase of Th2 cytokine levels were measured in the bronchoalveolar lavage fluid and via the inflammation of the lungs in ovalbumin-induced allergic asthma mice. CYM50358 administration before ovalbumin sensitization and before the antigen challenge strongly inhibited the increase of eosinophils and lymphocytes in the bronchoalveolar lavage fluid. CYM50358 administration inhibited the increase of IL-4 cytokines and serum IgE levels. Histological studies revealed that CYM50358 reduced inflammatory scores and PAS (periodic acid-Schiff)-stained cells in the lungs. The pro-allergic functions of S1P4 were elucidated using in vitro mast cells and in vivo ovalbumin-induced allergic asthma model experiments. These results suggest that S1P4 antagonist CYM50358 may have therapeutic potential in the treatment of allergic asthma.

기관지천식에서 기관지폐포세척액내 IL-10과 기도염증정도의 연관성 (Relation of Interleukin-10 in Bronchoalveolar Lavage Fluid and Airway Inflammation in Bronchial Asthma)

  • 이숙영;윤형규;신윤;이상학;김석찬;김관형;문화식;송정섭;박성학
    • Tuberculosis and Respiratory Diseases
    • /
    • 제46권1호
    • /
    • pp.44-52
    • /
    • 1999
  • 연구배경: 기관지천식은 호산구성 기도내 염증반응을 특징으로 하는데 호산구의 침윤에 관여하는 cytokine으로 T 림프구에서 분비되는 IL-3, IL-5, GM-CSF 등이 잘 알려져 있다. 한편 IL-10은 항염증성 cytokine으로 이러한 cytokine 분비를 억제할뿐만아니라, 호산구에 대해서는 직접적으로 자사(apoptosis)를 유도하고 조직내 첨착을 억제하는 기능을 갖고 있다. 본 연구에서는 기관지천식 환자에서의 기관지폐포세척액과 말초 혈액단핵세포에서 분비되는 IL-10을 정상대조군과 비교하고 기도내 염증반응정도와의 연관성을 분석하여 기관지천식에서의 IL-10 역할을 알아보고자 하였다. 방 법: 기관지천식환자 23명, 정상대조군 11명을 대상으로 기관지폐포세척액내와 말초혈액단핵구에서 분비되는 IL-10을 ELISA 방법으로 측정하고, 기도의 염증반응정도는 기관지세포세척액내 총세포수 및 호산구분율과 기관지 생검조직내 호산구 침윤정도, methacholine 기관지유발 검사에서 $PC_{20}$값으로 평가하였다. 결 과: 기관지폐포세척액내 IL-10과 말초혈액단핵구에서 분비되는 IL-10은 기관지천식 환자군과 정상대조군 사이에 통계적으로 유의한 차이는 없었다. 기관지천식환자군에서 기관지폐포세척액내 IL-10은 기관지폐포세척액내 호산구분율 및 기관지 조직내 침윤된 호산구수와는 유의한 역상관관계를 보였고, 메타콜린에 대한 PC20에 따른 차이는 없었다. 말초혈액단핵구에서 분비되는 IL-10은 기관지폐포세척액내 IL-10과 상관 관계가 없었으며, 말초혈액내 호산구수나 eosinophilic cationic protein과도 유의한 상관관계가 없었다. 결 론: 기관지천식 환자군의 기관지폐포세척액내 IL-10은 기관지폐포세척액이나 기관지 조직내 호산구 침윤과 역상관관계를 보였지만, 정상대조군과 비교해서 IL-10 감소가 관찰되지 않았기 때문에 기관지천식에서는 항염증 효과가 있는 IL-10이 중요하게 작용하지 않을 것으로 생각된다.

  • PDF

기관지천식에서의 신경적 기전 (Neural Mechanism in Bronchial Asthma)

  • 최병휘
    • Tuberculosis and Respiratory Diseases
    • /
    • 제41권2호
    • /
    • pp.73-86
    • /
    • 1994
  • In addition to classic cholinergic and adrenergic pathways, the existence of a third division of autonomic control in the human airways has been proved. It is called a nonadrenergic noncholinergic(NANC) nervous system, and difficult to study in the absence of specific blockers. Neuropeptides are certainly suggested to be transmitters of this NANC nervous system. It is very frustrating to understand the pathophysiologic role of these peptides in the absence of any specific antagonists. However, further studies of neuropeptides might eventually lead to novel forms of treatment for bronchial asthma. Another study of the interaction between different components of the autonomic nervous system, either in ganglionic neurotransmission or by presynaptic modulation of neurotransmitters at the end-organ will elute neural control in airway disease, particularly in asthma. Studies of how autonomic control may be disordered in airway disease should lead to improvements in clinical management. Epithelial damage due to airway inflammation in asthma may induce bronchial hyperresponsiveness. Axon reflex mechanism is one of possible mechanisms in bronchial hyperresponsiveness. Epithelial damage may expose sensory nerve terminals and C-fiber nrve endings are stimulated by inflammatory mediators. Bi-directional communication between the nerves and mast cells may have important roles in allergic process. The psychological factors and conditioning of allergic reactions is suggested that mast cell activation might be partly regulated by the central nervous system via the peripheral nerves. Studies in animal models, in huamn airways in vitro and in patients with airway disease will uncover the interaction between allergic disease processes and psychologic factors or neural mechainsms.

  • PDF

반하(半夏)가 천식모델 생쥐의 면역세포 및 사이토카인에 미치는 영향 (Effects of Pinelliae Rhizoma on immunocyte and cytokine production in asthma model mouse)

  • 송재진;박양춘
    • 대한한방내과학회지
    • /
    • 제26권1호
    • /
    • pp.156-168
    • /
    • 2005
  • Objective : The purpose of this research is to examine the effects of Pinelliae Rhizoma (PR) extract on immune cells and cytokines in ovalbumin (OVA)-induced asthmatic mice. Methods : In vivo, C57BL/6 mice were sensitized and handicapped by OVA for 12 weeks. During this experiment, the one group was then treated with PR extract for the 8 weeks (3 times per week) and analyzed by ELISA and flow cytometer. Results : In vivo, there were significant decreases in eosinophils, IL-4, IL-5, IL-13, IgE in BALF (bronchoalveolar lavage fluid) compared with that of control group. However, $IFN-{\gamma}$ in BALF of GS group increased significantly, compared with that of control group. Additionally, the population of $CD3e^-/CCR3^+,\;CD69^+/CD3e^+,\;IgE^+/B220^+,\;CD11b^+/Gr-l^+$ cells in the PR group decreased, compared with that of control group. Conclusion : The results of this study support a role for PR as an effective treatment for asthma in its experimental success in significantly decreasing inflammation and asthma reactions, and in increasing $IFN-{\gamma}$, which helps prevent such reactions.

  • PDF

소청룡탕 효능에 관한 기초 실험 연구 문헌 분석 (Analysis of Biological Experiment on Socheongryong-tang (Xiaoqinglong-tang))

  • 김정훈;신현규
    • 대한한의학회지
    • /
    • 제33권3호
    • /
    • pp.54-73
    • /
    • 2012
  • Objectives: To investigate the scientific evidence of Korean Medicine (KM), papers on Socheongryong-tang (Xiaoqinglong-tang), which is frequently used in medical clinics or hospitals of Korean medicine, were collected and analyzed. Methods: Papers were classified by the registration of domestic or international journals, the year of publication, experimental models and the subjects of biological activities. The mechanisms of biological activity in accordance with therapeutic effects of Socheongryong-tang (Xiaoqinglong-tang) were noted. Results: Among 98 papers included, 21 were published in domestic journals whereas 35 were in Chinese journals and 43 in Japanese journals. Most reported biological activities were amelioration of asthma. Socheongryong-tang (Xiaoqinglong-tang) regulated interleukin and interferon and immunoglobulin, inhibited the production of nerve growth factor, endotheliln-1, nitric oxide, toll-like receptor-4, p-Akt and increased extracellular signal regulated kinase and cyclin D1, which led to decreased bronchi inflammation and bronchoconstriction, and inhibited the proliferation of airway smooth muscle cells, mucus secretion and airway hyperresponsiveness. In addition, Socheongryong-tang (Xiaoqinglong-tang) also restored tissues injured by asthma so that respiratory function recovered. Conclusions: Amelioration of asthma by Socheongryong-tang (Xiaoqinglong-tang) is supported by objective and scientific evidence.

Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?

  • Bouazza, Belaid;Hadj-Said, Dihia;Pescatore, Karen A.;Chahed, Rachid
    • Tuberculosis and Respiratory Diseases
    • /
    • 제84권1호
    • /
    • pp.22-34
    • /
    • 2021
  • The coronavirus pandemic, known as coronavirus disease 2019 (COVID-19), is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus first identified in patients from Wuhan, China. Since December 2019, SARS-CoV-2 has spread swiftly around the world, infected more than 25 million people, and caused more than 800,000 deaths in 188 countries. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) appear to be risk factors for COVID-19, however, their prevalence remains controversial. In fact, studies in China reported lower rates of chronic respiratory conditions in patients with COVID-19 than in the general population, while the trend is reversed in the United States and Europe. Although the underlying molecular mechanisms of a possible interaction between COVID-19 and chronic respiratory diseases remain unknown, some observations can help to elucidate them. Indeed, physiological changes, immune response, or medications used against SARS-CoV-2 may have a greater impact on patients with chronic respiratory conditions already debilitated by chronic inflammation, dyspnea, and the use of immunosuppressant drugs like corticosteroids. In this review, we discuss importance and the impact of COVID-19 on asthma and COPD patients, the possible available treatments, and patient management during the pandemic.

기관지 과민성을 가진 장기간 천식 관해 상태의 청소년에서 혈액 내 호산구와 혈청 호산구 양이온 단백에 대한 연구 (Peripheral Blood Eosinophil Counts and Serum ECP in Adolescents with Long-term Asthma Remission and Persistent Bronchial Hyperresponsiveness : Comparison with Adolescents with Symptomatic Asthma)

  • 강희;유영;유진호;박양;고영률
    • Clinical and Experimental Pediatrics
    • /
    • 제46권10호
    • /
    • pp.1013-1018
    • /
    • 2003
  • 목 적 : 천식 환자에서 특징적으로 존재하는 BHR의 기전으로 호산구성 기도 염증 반응이 중요시 생각되고 있다. 그러나 장기간 천식 관해 상태인 청소년에서 BHR이 지속되는 기전에 대해서는 아직 명확하지 않은 실정이다. 본 연구는 장기간 천식 관해 된 청소년에서의 BHR이 호산구성 기도 혈액내 총 호산구 증가와 혈청 ECP 농도의 증가와 연관되어 있는지 알아보고자 시행하였다. 방 법 : 서울대학교 어린이병원 소아과 외래에서 아토피성 천식으로 진단되었던 청소년 중 임상적으로 장기간 관해(최근 2년간 천식 증상이 없고 치료가 필요 없었던 경우)되었으나 BHR이 잔존하는 35명과 이들과 서로 대응하는 BHR을 갖고 있으면서 현증을 보이는 아토피 천식 청소년 35명을 대상으로 하였다. 이 두 군간의 총 호산구 수와 혈청 ECP 농도를 비교하고 각 군에서 총 호산구 수 및 혈청 ECP 농도와 $PC_{20}$ 사이에 상관 관계가 있는 지 분석하였다. 결 과 : 장기간 관해 된 군의 혈액 내 호산구 수와 혈청 ECP 농도의 평균값이 현증을 보이는 군보다 통계적으로 유의하게 낮았다($273{\pm}108$ vs. $365{\pm}178/{\mu}L$; $16.3{\pm}9.4$ vs. $26.5{\pm}15.1{\mu}g/L$, both, P<0.05). 현증을 보이는 군에서는 메타콜린 $PC_{20}$에 따라 혈액 내 호산구 수 및 혈청 ECP 농도가 각각 통계적으로 유의한 음의 상관관계를 보였으나(r=-0.385, P=0.022; r=-0.439, P=0.008) 장기간 관해 된 군에서는 유의한 상관관계를 보이지 않았다(r=-0.292, P=0.089; r=-0.243, P=0.159). 결 론 : 이와 같은 소견은 장기간 관해시의 BHR은 호산구성 염증과 연관성이 없으며 현증 천식에서의 BHR과는 다른 기전으로 설명될 수 있을 것으로 추정된다. 장기간 천식 관해 된 청소년에서 BHR이 잔존하는 기전에 대하여 정확히 밝히기 위해서 향후 BAL, 조직 검사, 유도 객담 등을 이용한 연구를 시행할 필요가 있다.